|
NXT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.104100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.400100E-04 |
| Normal-vs-Stage2 |
5.383600E-01 |
| Normal-vs-Stage3 |
7.460600E-01 |
| Normal-vs-Stage4 |
4.165400E-01 |
| Stage1-vs-Stage2 |
2.006400E-01 |
| Stage1-vs-Stage3 |
5.886000E-02 |
| Stage1-vs-Stage4 |
5.956600E-01 |
| Stage2-vs-Stage3 |
7.891800E-01 |
| Stage2-vs-Stage4 |
7.601600E-01 |
| Stage3-vs-Stage4 |
5.961400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.420500E-03 |
| Normal-vs-AfricanAmerican |
5.604300E-02 |
| Normal-vs-Asian |
1.708810E-01 |
| Caucasian-vs-AfricanAmerican |
6.906000E-01 |
| Caucasian-vs-Asian |
9.949200E-01 |
| AfricanAmerican-vs-Asian |
8.890600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.828200E-04 |
| Normal-vs-Female |
7.636400E-01 |
| Male-vs-Female |
6.624800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.675300E-03 |
| Normal-vs-Extreme_Weight |
1.822720E-03 |
| Normal-vs-Obese |
2.837400E-01 |
| Normal-vs-Extreme_Obese |
1.589820E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.201600E-01 |
| Normal_Weight-vs-Obese |
1.310250E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.863000E-01 |
| Extreme_Weight-vs-Obese |
9.004100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.400200E-01 |
| Obese-vs-Extreme_Obese |
2.730200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.825800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.027250E-01 |
| Normal-vs-Age(61-80Yrs) |
9.167900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.590300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.116000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.325800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.976000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.520000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.638200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.539000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.381100E-03 |
| Normal-VS-Type2 PRCC |
2.958300E-02 |
| Normal-VS-KIRP CIMP |
5.614400E-02 |
| Normal-VS-Unclassified PRCC |
2.031000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.724000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.169800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.238800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.777800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.851000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.909800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.003800E-03 |
| Normal-vs-N1 |
4.020200E-01 |
| Normal-vs-N2 |
5.377800E-01 |
| N0-vs-N1 |
2.810400E-01 |
| N0-vs-N2 |
5.509800E-01 |
| N1-vs-N2 |
9.800400E-01 |
|
|
